Chronic delta hepatitis: from discovery to new treatments

Journal Title: One Health & Risk Management - Year 2021, Vol 2, Issue 2

Abstract

Introduction. Hepatitis delta virus (HDV) is a small, defective RNA virus that is related more to plant viroids than to other human pathogens. Material and methods. Nearly 50 research articles from various sources were reviewed and a comprehensive analysis was done regarding various parameters concerning HDV. Articles published over a period of 30 years were selected based on their experimental and statistical relevance to HDV. This review gives a brief insight into epidemiology, genetics, clinical evolution and treatment of chronic hepatitis delta. Results. Chronic hepatitis delta remains a major cause of morbidity in Eastern European countries and the Mediterranean region. At the same time, there is a resurgence of HBV and HDV infection in young people (under the age of 50) in Western Europe, as a consequence of the intra-familial and sexual mode of acquisition among immigrants from Eastern Europe, the Mediterranean region and from countries of the former Soviet Union, Africa high burdened regions of Asia and South America. Prevalence among IVDU was found to be higher especially in western european countries and other regions of low HDV prevalence. Chronic delta viral hepatitis is a dynamic, progressive process. A direct cytopathic pattern of liver tissue damage was also observed, especially in the presence of HDV genotype 3. Chronic hepatitis D is reported to progress to cirrhosis and hepatocellular cancer, and this trend is greater the higher the level of HDV viremia at the time of presentation. Conclusions. Flaws in screening and on-time diagnosis still remain due to the insufficient research and data available. While still not classified as a carcinogen by IARC, our review ends up in support of the notion that HDV infection increases the chances and fastens the pathogenic processes leading to HCC.

Authors and Affiliations

Adela TURCANU, Suhaib TAHIR WANI

Keywords

Related Articles

Epidemiological evolution of chronic hepatitis, liver cirrhosis and liver cancer in the Republic of Moldova

Introduction. The burden of liver diseases is a major health issue, being underestimated both at the national and international level. In the Republic of Moldova, there are over 70 thousand patients with chronic hepatiti...

Bibliometric analysis of research relating to noise pollution reported over the period

Introduction In the new globalized world, noise pollution has started to become a public health problem. We searched for publications about noise pollution in our study. In our study, we examined the noise pollution arti...

Possible algorithms for determining adverse reactions caused by food supplements in Romania

Introduction. The advertising of food supplements on various media channels or in specialty stores with natural products and other places, as well as the lack of informative and educational programs for the population up...

Biochemical composition changes of gram-negative microorganisms under the action of new chemical compounds

Introduction. It is known that the enzymes catalase (CT) and superoxide dismutase (SOD) are actively involved in protecting cells of microbial pathogens against the biochemical factors produced by macrophages in vivo, in...

Cardiovascular damage in seronegative spondylarthriti

Introduction. Cardiovascular mortality in patients diagnosed with seronegative spondyloarthritis (SSN) is on the rise. Impairment of the cardiovascular system in ankylosing spondylitis (SpA) is 20-40%, in psoriatic arthr...

Download PDF file
  • EP ID EP693657
  • DOI 10.38045/ohrm.2021.2.03
  • Views 125
  • Downloads 0

How To Cite

Adela TURCANU, Suhaib TAHIR WANI (2021). Chronic delta hepatitis: from discovery to new treatments. One Health & Risk Management, 2(2), -. https://europub.co.uk/articles/-A-693657